These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

75 related articles for article (PubMed ID: 24507315)

  • 1. Preparation, characterization and pulmonary pharmacokinetics of xyloglucan microspheres as dry powder inhalation.
    Mahajan HS; Gundare SA
    Carbohydr Polym; 2014 Feb; 102():529-36. PubMed ID: 24507315
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Montelukast-loaded nanostructured lipid carriers: part II pulmonary drug delivery and in vitro-in vivo aerosol performance.
    Patil-Gadhe A; Kyadarkunte A; Patole M; Pokharkar V
    Eur J Pharm Biopharm; 2014 Sep; 88(1):169-77. PubMed ID: 25078860
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The preparation and application of pulmonary surfactant nanoparticles as absorption enhancers in insulin dry powder delivery.
    Zhang Y; Zhu J; Tang Y; Chen X; Yang Y
    Drug Dev Ind Pharm; 2009 Sep; 35(9):1059-65. PubMed ID: 19640250
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Dry powder inhalations containing thymopentin and its immunomodulating effects in Wistar rats.
    Gao J; Ding X; Chu C; Lu L; Zhang Y; Chen Y; Fan W; Li G; Gao S
    Eur J Pharm Sci; 2009 Mar; 36(4-5):572-9. PubMed ID: 19135531
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pulmonary delivery of therapeutic peptides via dry powder inhalation: effects of micronisation and manufacturing.
    Irngartinger M; Camuglia V; Damm M; Goede J; Frijlink HW
    Eur J Pharm Biopharm; 2004 Jul; 58(1):7-14. PubMed ID: 15207532
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Improvement of Oral Bioavailability of Lopinavir Without Co-administration of Ritonavir Using Microspheres of Thiolated Xyloglucan.
    Madgulkar AR; Bhalekar MR; Kadam AA
    AAPS PharmSciTech; 2018 Jan; 19(1):293-302. PubMed ID: 28717974
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Chitosan microspheres for intrapulmonary administration of moxifloxacin: interaction with biomembrane models and in vitro permeation studies.
    Ventura CA; Tommasini S; Crupi E; Giannone I; Cardile V; Musumeci T; Puglisi G
    Eur J Pharm Biopharm; 2008 Feb; 68(2):235-44. PubMed ID: 17614266
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Physicochemical characterization and aerosol dispersion performance of organic solution advanced spray-dried microparticulate/nanoparticulate antibiotic dry powders of tobramycin and azithromycin for pulmonary inhalation aerosol delivery.
    Li X; Vogt FG; Hayes D; Mansour HM
    Eur J Pharm Sci; 2014 Feb; 52():191-205. PubMed ID: 24215736
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Novel sustained release microspheres for pulmonary drug delivery.
    Cook RO; Pannu RK; Kellaway IW
    J Control Release; 2005 May; 104(1):79-90. PubMed ID: 15866336
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Advanced spray-dried design, physicochemical characterization, and aerosol dispersion performance of vancomycin and clarithromycin multifunctional controlled release particles for targeted respiratory delivery as dry powder inhalation aerosols.
    Park CW; Li X; Vogt FG; Hayes D; Zwischenberger JB; Park ES; Mansour HM
    Int J Pharm; 2013 Oct; 455(1-2):374-92. PubMed ID: 23820131
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Formulation and in vivo evaluation of sodium alendronate spray-dried microparticles intended for lung delivery.
    Cruz L; Fattal E; Tasso L; Freitas GC; Carregaro AB; Guterres SS; Pohlmann AR; Tsapis N
    J Control Release; 2011 Jun; 152(3):370-5. PubMed ID: 21396412
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Preparation and evaluation of poly(lactic-co-glycolic acid) microparticles as a carrier for pulmonary delivery of recombinant human interleukin-2: II. In vitro studies on aerodynamic properties of dry powder inhaler formulations.
    Devrim B; Bozkır A; Canefe K
    Drug Dev Ind Pharm; 2011 Nov; 37(11):1376-86. PubMed ID: 21548727
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Physical characteristics and aerosolization performance of insulin dry powders for inhalation prepared by a spray drying method.
    You Y; Zhao M; Liu G; Tang X
    J Pharm Pharmacol; 2007 Jul; 59(7):927-34. PubMed ID: 17637186
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Preparation and characterization of spray-dried tobramycin powders containing nanoparticles for pulmonary delivery.
    Pilcer G; Vanderbist F; Amighi K
    Int J Pharm; 2009 Jan; 365(1-2):162-9. PubMed ID: 18782609
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Optimized pulmonary gene transfection in mice by spray-freeze dried powder inhalation.
    Mohri K; Okuda T; Mori A; Danjo K; Okamoto H
    J Control Release; 2010 Jun; 144(2):221-6. PubMed ID: 20184930
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pulmonary delivery of growth hormone using dry powders and visualization of its local fate in rats.
    Bosquillon C; Préat V; Vanbever R
    J Control Release; 2004 Apr; 96(2):233-44. PubMed ID: 15081215
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Formulation, optimization and evaluation of spray-dried mucoadhesive microspheres as intranasal carriers for Valsartan.
    Pardeshi CV; Rajput PV; Belgamwar VS; Tekade AR
    J Microencapsul; 2012; 29(2):103-14. PubMed ID: 22047546
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Development of inhalable dry powder formulation of basic fibroblast growth factor.
    Ibrahim BM; Jun SW; Lee MY; Kang SH; Yeo Y
    Int J Pharm; 2010 Jan; 385(1-2):66-72. PubMed ID: 19853028
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Surfactant-free redispersible nanoparticles in fast-dissolving composite microcarriers for dry-powder inhalation.
    Lebhardt T; Roesler S; Uusitalo HP; Kissel T
    Eur J Pharm Biopharm; 2011 May; 78(1):90-6. PubMed ID: 21145394
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Spray freeze drying to produce a stable Delta(9)-tetrahydrocannabinol containing inulin-based solid dispersion powder suitable for inhalation.
    van Drooge DJ; Hinrichs WL; Dickhoff BH; Elli MN; Visser MR; Zijlstra GS; Frijlink HW
    Eur J Pharm Sci; 2005 Oct; 26(2):231-40. PubMed ID: 16084699
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.